<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE root>
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="other" dtd-version="1.2" xml:lang="en"><front><journal-meta><journal-id journal-id-type="publisher-id">Bone and soft tissue sarcomas, tumors of the skin</journal-id><journal-title-group><journal-title xml:lang="en">Bone and soft tissue sarcomas, tumors of the skin</journal-title><trans-title-group xml:lang="ru"><trans-title>Саркомы костей, мягких тканей и опухоли кожи</trans-title></trans-title-group></journal-title-group><issn publication-format="print">2219-4614</issn><issn publication-format="electronic">2782-3687</issn><publisher><publisher-name xml:lang="en">Publishing House ABV Press</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">567</article-id><article-id pub-id-type="doi">10.17650/2782-3687-2022-14-2-36-43</article-id><article-categories><subj-group subj-group-type="toc-heading" xml:lang="en"><subject>BONE SARCOMAS</subject></subj-group><subj-group subj-group-type="toc-heading" xml:lang="ru"><subject>САРКОМЫ КОСТЕЙ</subject></subj-group><subj-group subj-group-type="article-type"><subject></subject></subj-group></article-categories><title-group><article-title xml:lang="en">Pelvic endoprosthesis in tumor lesions: experience of N.N. Petrov National Medical Research Center of Oncology</article-title><trans-title-group xml:lang="ru"><trans-title>Эндопротезирование тазового кольца при опухолевом поражении: опыт Национального медицинского исследовательского центра онкологии им. Н.Н. Петрова</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-3172-2201</contrib-id><name-alternatives><name xml:lang="en"><surname>Gafton</surname><given-names>G. I.</given-names></name><name xml:lang="ru"><surname>Гафтон</surname><given-names>Г. И.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>68 Leningradskaya St., Pesoсhny Settlement, Saint-Petersburg 197758</p></bio><bio xml:lang="ru"><p>197758 Санкт-Петербург, пос. Песочный, ул. Ленинградская, 68</p></bio><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Gudz</surname><given-names>Y. V.</given-names></name><name xml:lang="ru"><surname>Гудзь</surname><given-names>Ю. В.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>68 Leningradskaya St., Pesoсhny Settlement, Saint-Petersburg 197758</p></bio><bio xml:lang="ru"><p>197758 Санкт-Петербург, пос. Песочный, ул. Ленинградская, 68</p></bio><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-1639-2443</contrib-id><name-alternatives><name xml:lang="en"><surname>Zinovev</surname><given-names>G. V.</given-names></name><name xml:lang="ru"><surname>Зиновьев</surname><given-names>Г. В.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>68 Leningradskaya St., Pesoсhny Settlement, Saint-Petersburg 197758</p></bio><bio xml:lang="ru"><p>197758 Санкт-Петербург, пос. Песочный, ул. Ленинградская, 68</p></bio><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-7304-8214</contrib-id><name-alternatives><name xml:lang="en"><surname>Ebert</surname><given-names>M. A.</given-names></name><name xml:lang="ru"><surname>Эберт</surname><given-names>М. А.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>Maria Albertovna Ebert</p><p>68 Leningradskaya St., Pesoсhny Settlement, Saint-Petersburg 197758</p></bio><bio xml:lang="ru"><p>Мария Альбертовна Эберт</p><p>197758 Санкт-Петербург, пос. Песочный, ул. Ленинградская, 68</p></bio><email>mary.ebert.spb@gmail.com</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-6694-1258</contrib-id><name-alternatives><name xml:lang="en"><surname>Gafton</surname><given-names>I. G.</given-names></name><name xml:lang="ru"><surname>Гафтон</surname><given-names>И. Г.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>68 Leningradskaya St., Pesoсhny Settlement, Saint-Petersburg 197758</p></bio><bio xml:lang="ru"><p>197758 Санкт-Петербург, пос. Песочный, ул. Ленинградская, 68</p></bio><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-0809-7495</contrib-id><name-alternatives><name xml:lang="en"><surname>Sinyachkin</surname><given-names>M. S.</given-names></name><name xml:lang="ru"><surname>Синячкин</surname><given-names>М. С.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>68 Leningradskaya St., Pesoсhny Settlement, Saint-Petersburg 197758</p></bio><bio xml:lang="ru"><p>197758 Санкт-Петербург, пос. Песочный, ул. Ленинградская, 68</p></bio><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-6399-2399</contrib-id><name-alternatives><name xml:lang="en"><surname>Borodulin</surname><given-names>A. V.</given-names></name><name xml:lang="ru"><surname>Бородулин</surname><given-names>А. В.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>68 Leningradskaya St., Pesoсhny Settlement, Saint-Petersburg 197758</p></bio><bio xml:lang="ru"><p>197758 Санкт-Петербург, пос. Песочный, ул. Ленинградская, 68</p></bio><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-9885-1177</contrib-id><name-alternatives><name xml:lang="en"><surname>Gogolev</surname><given-names>A. B.</given-names></name><name xml:lang="ru"><surname>Гоголев</surname><given-names>А. Б.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>68 Leningradskaya St., Pesoсhny Settlement, Saint-Petersburg 197758</p></bio><bio xml:lang="ru"><p>197758 Санкт-Петербург, пос. Песочный, ул. Ленинградская, 68</p></bio><xref ref-type="aff" rid="aff1"/></contrib></contrib-group><aff-alternatives id="aff1"><aff><institution xml:lang="en">N.N. Petrov National Medical Research Center of Oncology, Ministry of Health of Russia</institution></aff><aff><institution xml:lang="ru">ФГБУ «Национальный медицинский исследовательский центр онкологии им. Н.Н. Петрова» Минздрава России</institution></aff></aff-alternatives><pub-date date-type="pub" iso-8601-date="2022-07-07" publication-format="electronic"><day>07</day><month>07</month><year>2022</year></pub-date><volume>14</volume><issue>2</issue><issue-title xml:lang="en"/><issue-title xml:lang="ru"/><history><date date-type="received" iso-8601-date="2022-07-07"><day>07</day><month>07</month><year>2022</year></date><date date-type="accepted" iso-8601-date="2022-07-07"><day>07</day><month>07</month><year>2022</year></date></history><permissions><copyright-statement xml:lang="en">Copyright ©; 2022, Gafton G.I., Gudz Y.V., Zinovev G.V., Ebert M.A., Gafton I.G., Sinyachkin M.S., Borodulin A.V., Gogolev A.B.</copyright-statement><copyright-statement xml:lang="ru">Copyright ©; 2022, Гафтон Г.И., Гудзь Ю.В., Зиновьев Г.В., Эберт М.А., Гафтон И.Г., Синячкин М.С., Бородулин А.В., Гоголев А.Б.</copyright-statement><copyright-year>2022</copyright-year><copyright-holder xml:lang="en">Gafton G.I., Gudz Y.V., Zinovev G.V., Ebert M.A., Gafton I.G., Sinyachkin M.S., Borodulin A.V., Gogolev A.B.</copyright-holder><copyright-holder xml:lang="ru">Гафтон Г.И., Гудзь Ю.В., Зиновьев Г.В., Эберт М.А., Гафтон И.Г., Синячкин М.С., Бородулин А.В., Гоголев А.Б.</copyright-holder><ali:free_to_read xmlns:ali="http://www.niso.org/schemas/ali/1.0/"/><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/">https://creativecommons.org/licenses/by/4.0</ali:license_ref></license></permissions><self-uri xlink:href="https://sarbon.abvpress.ru/jour/article/view/567">https://sarbon.abvpress.ru/jour/article/view/567</self-uri><abstract xml:lang="en"><p><bold>Introduction</bold>. Oncological endoprosthesis for tumors of the pelvic bones is rare. It is associated with certain difficulties and is insufficiently investigated.<bold>The study objective</bold> is to evaluate the results of surgical treatment of patients with tumors of the pelvis performed between 2012 and 2021 at the N.N. Petrov National Medical Research Center of Oncology, Ministry of Health of Russia.<bold>Materials and methods</bold>. The study included 23 patients with primary and secondary tumors of the pelvic bones who underwent limb-saving surgeries with substitution of the postresection defect with an endoprosthesis between 2012 and 2021. Mean follow-up duration was 19 months.<bold>Results</bold>. The most common postoperative complication was infection of the postoperative wound (n = 8; 35 %). Mechanical complications associated with the installed metallic prosthesis were observed in 4 (17 %) patients. Function al results were evaluated after 6 months using the Musculoskeletal Tumor Society Score (MSTS). Mean score per this scale was 53 % which corresponds to satisfactory outcome.<bold>Conclusion</bold>. Patients with malignant tumors of the pelvic bones should undergo treatment only in specialized medical facilities. Patients for organ-saving therapy should be carefully selected.</p></abstract><trans-abstract xml:lang="ru"><p><bold>Введение</bold>. Онкологическое эндопротезирование при опухолевом поражении костей таза проводится довольно редко. Оно сопряжено с определенными трудностями и в настоящий момент остается малоизученным.<bold>Цель исследования</bold> – оценить результаты хирургического лечения пациентов с опухолевым поражением костей тазового пояса, проведенного в 2012–2021 гг. в Национальном медицинском исследовательском центре онкологии им. Н.Н. Петрова Минздрава России.<bold>Материалы и методы</bold>. В исследование включены 23 пациента с первичными и вторичными опухолями костей таза, которым с 2012 по 2021 г. выполнены сохраняющие конечность операции с замещением пострезекционного дефекта эндопротезом. Средний период наблюдения составил 19 мес.<bold>Результаты</bold>. Наиболее частым послеоперационным осложнением было инфицирование послеоперационной раны (n = 8; 35 %). Механические осложнения, связанные с установленной металлоконструкцией, возникли у 4 (17 %) пациентов. Функциональные результаты оценивали через 6 мес по шкале Международного общества опухолей опорно-двигательного аппарата (Musculoskeletal Tumor Society Score, MSTS). Средний показатель по этой шкале составил 53 %, что соответствует удовлетворительным результатам.<bold>Заключение</bold>. Пациенты со злокачественными новообразованиями костей таза должны проходить лечение только в специализированных учреждениях. Необходимо тщательно отбирать больных для органосохраняющей терапии.</p></trans-abstract><kwd-group xml:lang="en"><kwd>sarcoma</kwd><kwd>pelvic sarcoma</kwd><kwd>pelvic endoprosthesis</kwd></kwd-group><kwd-group xml:lang="ru"><kwd>саркомы</kwd><kwd>саркомы костей таза</kwd><kwd>эндопротезирование тазового кольца</kwd></kwd-group><funding-group/></article-meta></front><body></body><back><ref-list><ref id="B1"><label>1.</label><citation-alternatives><mixed-citation xml:lang="en">Malignant neoplasms in Russia in 2018 (morbidity and mortality). Ed. by A.D. Kaprin, V.V. Starinsky, G.V. Petrova. Moscow: P.A. Herzen Moscow State Medical Research Institute – branch of the Federal State Budgetary Institution “NMIC of Radiology” of the Ministry of Health of Russia, 2019. 250 p. (In Russ.).</mixed-citation><mixed-citation xml:lang="ru">Злокачественные новообразования в России в 2018 году (заболеваемость и смертность). Под ред. А.Д. Каприна, В.В. Старинского, Г.В. Петровой. М.: МНИОИ им. П.А. Герцена – филиал ФГБУ «НМИЦ радиологии» Минздрава России, 2019. 250 с.</mixed-citation></citation-alternatives></ref><ref id="B2"><label>2.</label><mixed-citation>Hu X., Deng K., Ye H. et al. Trends in tumor site-specific survival of bone sarcomas from 1980 to 2018: a surveillance, epidemiology and end results-based study. Cancers 2021;13(21):5381. DOI: 10.3390/cancers13215381.</mixed-citation></ref><ref id="B3"><label>3.</label><mixed-citation>Enneking W.F., Dunham W.K. Resection and reconstruction for primary neoplasms involving the in nominate bone. J Bone Joint Surg Am 1978;60(6):731–46.</mixed-citation></ref><ref id="B4"><label>4.</label><mixed-citation>Lowe M., Jeys L., Grimer R., Parry M. Pelvic reconstruction using pedestal endoprosthesis – experience from Europe. Ann Joint 2019;4:34. DOI: 10.21037/aoj.2019.06.04.</mixed-citation></ref><ref id="B5"><label>5.</label><mixed-citation>Shao Q.D., Yan X., Sun J.Y. et. al. Internal hemipelvectomy with reconstruction for primary pelvic neoplasm: a systematic review. ANZ J Surg 2015;85(7–8):553–60. DOI: 10.1111/ans.12895.</mixed-citation></ref><ref id="B6"><label>6.</label><mixed-citation>Miwa S., Shirai T., Yamamoto N. et al. Risk factors for surgical site infection after malignant bone tumor resection and reconstruction. BMC Cancer 2019;19(1):33. DOI: 10.1186/s12885-019-5270-8.</mixed-citation></ref><ref id="B7"><label>7.</label><mixed-citation>Lackman R.D., Crawford E.A., Hosalkar H.S. et al. Internal hemipelvectomy for pelvic sarcomas using a T-incision surgical approach. Clin Orthop 2009;467(10):2677–84. DOI: 10.1007/s11999-009-0843-5.</mixed-citation></ref><ref id="B8"><label>8.</label><mixed-citation>Guo W., Li D., Tang X., Yang Y., Ji T. Reconstruction with modular hemipelvic prostheses for periacetabular tumor. Clin Orthop Relat Res 2007;461:180–8. DOI: 10.1097/ blo.0b013e31806165d5.</mixed-citation></ref><ref id="B9"><label>9.</label><mixed-citation>Sun W., Li J., Li Q. et al. Clinical effectiveness of hemipelvic reconstruction using computer-aided custom-made prostheses after resection of malignant pelvic tumors. J Arthroplasty 2011;26(8):1508–13. DOI: 10.1016/j.arth.2011.02.018.</mixed-citation></ref><ref id="B10"><label>10.</label><mixed-citation>Court C., Bosca L., Le Cesne A. et al. Surgical excision of bone sarcomas involving the sacroiliac joint. Clin Orthop Relat Res 2006;451:189–94. DOI: 10.1097/01.blo.0000229279.58947.91.</mixed-citation></ref><ref id="B11"><label>11.</label><mixed-citation>Barrientos-Ruiz I., Ortiz-Cruz E.J. Reconstruction after hemipelvectomy with the ice-cream cone prosthesis: what are the short-term clinical results? Clin Orthop Relat Res Symposium: 2015 meetings of the musculoskeletal tumor society and the international society of limb salvage 2017;475(3):735–41. DOI: 10.1007/s11999-016-4747-x.</mixed-citation></ref><ref id="B12"><label>12.</label><mixed-citation>Sanders P.T.J., Bus M.P.A., Scheper H. et al. Multiflora and gram-negative microorganisms predominate in infections affecting pelvic endoprostheses following tumor resection. J Bone Joint Surg Am 2019;101(9):797–803. DOI: 10.2106/JBJS.18.00836.</mixed-citation></ref><ref id="B13"><label>13.</label><mixed-citation>Tande A.J., Patel R. Prosthetic joint infection. Clin Microbiol Rev 2014;27(2):302–45. DOI: 10.1128/CMR.00111-13.</mixed-citation></ref><ref id="B14"><label>14.</label><mixed-citation>Bus M., Szafranski A., Sellevold S. et al. LUMiC endoprosthetic reconstruction after periacetabular tumor resection: short-term results. Clin Orthop Relat Res 2017;475(3):686–95. DOI: 10.1007/s11999-016-4805-4.</mixed-citation></ref><ref id="B15"><label>15.</label><mixed-citation>Dai K.R., Yan M.N., Zhu Z.A., Sun Y.H. Computer-aided custom-made hemipelvic prosthesis used in extensive pelvic lesions. J Arthroplast 2007;22:981–6. DOI: 10.1016/j.arth.2007.05.002.</mixed-citation></ref><ref id="B16"><label>16.</label><mixed-citation>Wang B., Hao Y., Pu F. et al. Computeraided designed, three-dimensional-printed hemipelvic prosthesis for periacetabular malignant bone tumour. Int Orthop 2018;42(3):687–94.</mixed-citation></ref><ref id="B17"><label>17.</label><mixed-citation>Angelini A., Trovarelli G., Berizzi A. et al. Three-dimension-printed custom-made prosthetic reconstructions: from revision surgery to oncologic reconstructions. Int Orthop 2019;43(1):123–32. DOI: 10.1007/ s00264-018-4232-0.</mixed-citation></ref><ref id="B18"><label>18.</label><mixed-citation>Angelini A., Kotrych D., Trovarelli G. et al. Analysis of principles inspiring design of three-dimensional-printed custom-made prostheses in two referral centres. Int Orthop 2020;44(5):829–37. DOI: 10.1007/s00264-020-04523-y.</mixed-citation></ref><ref id="B19"><label>19.</label><mixed-citation>Witte D., Bernd L., Bruns J. et al. Limb-salvage reconstruction with MUTARS hemipelvic endoprosthesis: a prospective multicenter study. Eur J Surg Oncol 2009;35(12):1318–25. DOI: 10.1016/j.ejso.2009.04.011.</mixed-citation></ref></ref-list></back></article>
